Adjuvant.Health Revenue and Competitors
Estimated Revenue & Valuation
- Adjuvant.Health's estimated annual revenue is currently $10.8M per year.
- Adjuvant.Health's estimated revenue per employee is $216,000
Employee Data
- Adjuvant.Health has 50 Employees.
- Adjuvant.Health grew their employee count by -6% last year.
Adjuvant.Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 32 | 3% | N/A | N/A |
#2 | $13.4M | 55 | 10% | N/A | N/A |
#3 | $25.4M | 94 | 11% | N/A | N/A |
#4 | $78.4M | 264 | 16% | N/A | N/A |
#5 | $9.3M | 43 | 10% | N/A | N/A |
#6 | $51.1M | 172 | 24% | N/A | N/A |
#7 | $65M | 219 | 0% | N/A | N/A |
#8 | $44.8M | 151 | 9% | N/A | N/A |
#9 | $6.7M | 31 | -11% | N/A | N/A |
#10 | $9.5M | 44 | 7% | N/A | N/A |
What Is Adjuvant.Health?
Adjuvant.Health, powered by Allied Physicians Group. Adjuvant.Health supports all Physician business and administrative needs by our highly trained and dedicated home office team. This allows the physician to focus on patient care while we focus on administrative operations. Ultimately creating a better work-life balance. As a forward-thinking organization that continually searches for new, innovative approaches to the practice of medicine. Adjuvant.Health provides a full suite of consultative services. Our suite of offerings include Accounting and Financial Services, Analytical and Quality Reporting, Malpractice Management, Compliance and Technology services, Human Resources and Benefit Management, NCQA/PCMH Certification, RCM/Billing Support, Telehealth Program, Marketing and PR, and Office Manager Enrichment Programs.
keywords:N/AN/A
Total Funding
50
Number of Employees
$10.8M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.8M | 50 | 2% | N/A |
#2 | $10M | 50 | 0% | N/A |
#3 | $6.7M | 51 | N/A | N/A |
#4 | $13.1M | 54 | 8% | N/A |
#5 | N/A | 55 | 34% | N/A |